As long as you know the equipment is already FDA approved, beta products are designed (potential product) product management is in close to ready mode, and sales nets will probably take a JV form ,,,, then you would have to say charts/time may only show higher highs and higher lows.
If people want to say the pps is to be less valued than the value than before the new managment was brought in to monitize the product fine. If saying all charts point to eventual return to a base line fine.
I've just not seen this to be the case where, as you say, production and distribution start up was ahead, rather than behind.
It's obvious you read charts and momo, but, if that is all there is to prediction, ones average on gains becomes diluted.
Myself, and I agree with you on a rocket potential, predicting the base line endlessly is no more predictable than the timeline to the news,,, so what is your model on timeline affects/advances in detail towards requirements supporting for "that big news" to take a year?
Or to say, what is the event sequence,, in detail please, specific to this equitys particulars that require a year.
